Dr. Martens commands a high Ebitda multiple with its IPO

2021-01-27T10:04:00

Dr. Martens logo

Dr. Martens is being valued between £3.3-3.7 billion (€3.7bn-$4.5bn to €4.2bn-$5.1bn) in its planned public offering on the London Stock Exchange, whichis already fully booked. The valuation implies a multiple of over 17 times Ebitda, as the company generated Ebitda of £184 million (€204.2m-$248.3m) on revenues of £672 million (€745.8m-$907m) ...

SIGN-IN  if you are already a subscriber of SGI Europe

Gated access promo

Become an SGI Europe Professional subscriber

Get access to what the top decision makers are reading in the sporting goods industry:

  • Access  to all SGI Europe news across 14 coverage areas (Retail, Corporate & M&A, Financial, Product, Marketing, Trade & Sourcing, Sustainability, Technology,…)
  • Access exclusive content  before it breaks to the public, scoops and breaking news
  • Essential E-mail Briefings  with the latest analysis and most important industry developments of the international market
  • C-Suite Interviews, guest chronicles  from industry experts and leaders that are shaping the future of the industry
  • Organisation-wide access  across offices, people and devices

SUBSCRIBE TODAY!

View all subscription plans on our subscription page.